Loading…

Baxter will buy the Seprafilm adhesion barrier and related assets from Sanofi in a $350 million deal expected to close by Q1 2020.
“While Seprafilm is clinically recognized among surgeons globally, we plan to provide commercial support for the product through our dedicated surgery salesforce.”massdevice.com
Summarized from public sources; check the original articles before acting on it.